Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

Clinical trial NCT00736879 · COMPLETED

Trial details

NCT number: NCT00736879
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-09-22
Primary completion: 2009-12-29
Enrollment: 497

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.